ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (LGND)

73.10
1.83
(2.57%)
At close: March 28 04:00PM
73.10
1.83
( 2.57% )
After Hours: 04:01PM

Ligand Pharmaceuticals Incorporated Financial Summary

The current LGND market cap is 1.29B. The company's latest EPS is USD 2.9457 and P/E is 24.78.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 66.09M27.05M43.98M26.37M34.99M
Operating Income 636k12.18M14.21M-1.98M3.08M
Net Income 404k-17.49M41.95M2.29M-10.27M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 120.28M186.42M314.73M196.25M131.31M
Operating Income -5.72M8.73M78.9M3.04M9.82M
Net Income 629.3M-2.99M57.14M-33.36M52.15M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.05B762.67M811.08M758.11M769.23M
Total Liabilities 234.31M165.18M164.76M93.21M101.33M
Total Equity 816.3M597.49M646.32M664.89M667.9M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.49B1.36B1.3B762.67M787.22M
Total Liabilities 727.68M652.76M476.43M165.18M86.3M
Total Equity 767.23M709.53M821.16M597.49M700.91M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 84.38M137.85M33.95M33.87M41.51M
Investing 170.91M163.62M10.55M18.11M-1.4M
Financing -270.69M-275.99M-775k-68.53M-65.26M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -29.34M54.59M78.8M137.85M49.58M
Investing 466.92M231.65M30.52M163.62M-11.68M
Financing -485.17M-310.55M-137.76M-275.99M-59.95M
Market Cap 1.29B
Price to Earnings Ratio 24.78
Price to Sales Ratio 9.84
Price to Cash Ratio 56.31
Price to Book Ratio 1.84
Dividend Yield -

Share Statistics

Shares Outstanding 17.71M
Average Volume (1 week) 113.07k
Average Volume (1 Month) 209.77k
52 Week Change 4.04%
52 Week High 94.57
52 Week Low 49.24
Spread (Intraday) 2.21 (2.96%)

Company Info

Company Name Ligand Pharmaceuticals Incorporated
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.ligand.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock